SCHEMBL22818286

SCHEMBL22818286

c1ccc(-c2ccccc2-c2cc3c(oc4cccc(N(c5ccccc5-c5ccccc5)c5cccc6ccccc56)c43)c3ccccc23)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.34
▸ ALDH1A1 P00352 7/20 0.33
▸ KDM4E B2RXH2 5/20 0.33
▸ MAPT P10636 5/20 0.33
▸ HPGD P15428 5/20 0.33
▸ HSD17B10 Q99714 5/20 0.33
▸ TSHR P16473 4/20 0.33
▸ MAPK1 P28482 3/20 0.33
▸ TP53 P04637 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ MAOB P27338 1/20 0.33
▸ CYP1A1 P04798 4/20 0.32
▸ CYP1A2 P05177 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22817763 0.98 ALOX5 (0.35) ALOX5ALDH1A1KDM4EMAPTHPGD
SCHEMBL22818021 0.98 ALOX5 (0.35) ALOX5ALDH1A1KDM4EMAPTHPGD
SCHEMBL22818283 0.95 ALDH1A1 (0.36) ALOX5ALDH1A1KDM4EMAPTHPGD
SCHEMBL22818190 0.95 ALOX5 (0.35) ALOX5ALDH1A1KDM4EMAPTHPGD
SCHEMBL22817719 0.93 ALOX5 (0.35) ALOX5ALDH1A1KDM4EMAPTHPGD
SCHEMBL22818368 0.93 ALOX5 (0.36) ALOX5ALDH1A1KDM4EMAPTHPGD
SCHEMBL22817955 0.93 ALOX5 (0.36) ALOX5ALDH1A1KDM4EMAPTHPGD
SCHEMBL22818008 0.93 ALOX5 (0.36) ALOX5ALDH1A1KDM4EMAPTHPGD
SCHEMBL22818421 0.92 CYP1A1 (0.33) ALOX5ALDH1A1KDM4EMAPTHPGD
SCHEMBL22818225 0.92 KDM4E (0.36) ALOX5ALDH1A1KDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT MATERIALS CO., LTD. (KR) 2020-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same CRY1, CRY2, PER2 ALOX5 1385/4885ALDH1A1 1915/4885KDM4E 3261/4885
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, PER2 ALOX5 1385/4885ALDH1A1 1915/4885KDM4E 3261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback